Coronavirus Vaccine Update : 10 Developments from India and Around the World

Coronavirus Vaccine Update : With over 165 vaccines in the process of development, 140 plus vaccine candidates in pre-clinical trials, scientists and researchers are leaving no stone unturned in trying to develop a vaccine that is stable and provides immunization for an extended period of time. Many are still in the first phase of trials, and many have been garnering extremely positive results. There is nothing the world wants more than a vaccine for the virus to help rid us off of the deadly contagion, and resume life as it were before the pandemic.

Here are a few Coronavirus Vaccine Update from India and Around the World

Moderna and the N.I.H have entered the phase three trials for the vaccine. Only six vaccine candidates have until now, entered the third phase for the vaccine trial. Moderna is in partnership with N.I.H. (National Institute of health). The vaccine candidate began its first human trial in March, and has proven to stop the virus from spreading in monkeys. The phase III trials began on 27 July.
University of Oxford, in partnership with AstraZeneca has also developed a strong candidate which has been showing positive results in people, and is providing immunization. They are of the belief that the vaccine might be ready to launch by the end of the year. The final phase of vaccine have already started.
Pfizer, in collaboration with BioNtech, and Fosun Pharma to develop a vaccine for the virus. The vaccine is undergoing a combined phase II and phase III trials as of now. The previous phase I and phase II results showed that the vaccine was successful in providing immunization in people, and the ones given the vaccine developed antibodies for the novel coronavirus. The combines II and III phase trial will be done on almost 30,000 volunteers, as was stated on 27^th of July.
Another vaccine to have caught the headlines is Russia’s candidate, which claims to have been registered for use as early as August. The vaccine is relatively early, and began with its phase 2 trials from July 13^th, which makes it a little hard to believe that it will be registered for human use from August. The production of the vaccine is to be started from September this year.
Indian vaccine candidate Zydus Cadila, is the second in India after Covaxin, Bharat Biotech’s candidate. Zydus Cadila have announced that they have received approval to begin with the human trials as the results seem promising. The vaccine candidate will continue the human trial for next six months.
Bharat Biotech, which is in collaboration with the National Institute of Virology have started with their first phase of human trials last month, July. This phase of the trial will involve 375 volunteers who will be given the doses. The phase II trial will be on 720 people. Impressive results have inferred after the Phase I of the trial.
Arcturus Therapeutics and Duke-NUS Medical School Arcturus Therapeutics and Duke-NUS Medical School are working in collaboration to develop a vaccine for the novel coronavirus. During animal trials, their vaccine candidate yielded a positive response, and it proved to give immunization against the virus. They got approval for the phase I and II combined human trials on 21^st of July.
Another candidate for the vaccine is Johnson and Johnson. They began conducting their combined phase I and II trials in July, and are planning on continuing with their phase III trials from September. If deemed as viable, the company will make over a billion doses in the next year.
NOVAVAX, another vaccine candidate, which is a protein-based vaccine, began with their trials for the vaccine in May. They were given a grant of million USD for conducting their trials, by the US Government. If it provides an immune response in human beings, and does not cause any side-effects, then the USA will be delivered 100 million doses by the first quarter of 2021.
India’s SERUM Institute got permission to begin the human trial of Oxford Vaccine candidate in India. SERUM institute have also started manufacturing vaccine in India. The institute plans to make millions of doses of vaccine in three months.

With rising cases around the world and shrinking economy, vaccine development has become major priority of every country in the world. With major vaccine developing companies claiming of positive result from their vaccine candidates, world is hopeful of having Coronavirus Vaccine by end of this year or early months of 2021.

Coronavirus Vaccine Update : 10 Developments from India and Around the World

Read all our articles on Coronavirus Vaccine Update here